Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years Mauriello JA Jr; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MCBr J Ophthalmol 1996[Dec]; 80 (12): 1073-6BACKGROUND: A retrospective review of 239 patients with benign essential blepharospasm and Meige syndrome was performed in order to determine patients' long term treatment preferences. METHODS: Of 239 patients evaluated, 228 received local injections of botulinum toxin, type A, into the eyelid and facial musculature over 11 years. RESULTS: Of 228 patients, 202 (72.1%) were still treated with botulinum toxin, type A. Eighteen patients (6.9%) no longer received botulinum toxin injections and sought no other treatment. Five patients (2.2%) had apparent remission of their disease after injection. Three patients (1.3%) ultimately obtained relief from orbicularis muscle extirpative surgery and required no additional treatment. Two of the 11 patients (4.6%) who chose not to receive botulinum toxin injections were successfully treated with other modalities: psychotherapy (one patient) and oral haloperidol (one patient). CONCLUSION: While botulinum toxin is the most highly effective treatment for benign essential blepharospasm and Meige syndrome over a long period of time, adjunctive oral drug therapy, including minor tranquillisers as well as eyelid surgery, may augment its effectiveness.|Anti-Anxiety Agents/therapeutic use[MESH]|Anti-Dyskinesia Agents/adverse effects/*therapeutic use[MESH]|Anticonvulsants/therapeutic use[MESH]|Benzodiazepines[MESH]|Blepharospasm/*drug therapy[MESH]|Botulinum Toxins, Type A/adverse effects/*therapeutic use[MESH]|Cohort Studies[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Meige Syndrome/*drug therapy[MESH]|Muscle Relaxation[MESH]|Patient Acceptance of Health Care[MESH]|Retrospective Studies[MESH]|Treatment Outcome[MESH] |
